Edgewise Therapeutics

Edgewise Therapeutics

Biotechnology, 1715 38th St, Boulder, Colorado, 80301, United States, 51-200 Employees

edgewisetx.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 72********

Who is EDGEWISE THERAPEUTICS

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.

Read More

map
  • 1715 38th St, Boulder, Colorado, 80301, United States Headquarters: 1715 38th St, Boulder, Colorado, 80301, United States
  • 2017 Date Founded: 2017
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from EDGEWISE THERAPEUTICS

Edgewise Therapeutics Org Chart and Mapping

Employees

Craig Emter

Senior Director, Cardiovascular Pharmacology

Emily Dinatale

Senior Research Associate

John Wing

Senior Director Medical Affairs

Abby Bronson

VP Patient Advocacy and External Innovation

Ying Qian

Research Investigator

Amanda Pustelnikas

Senior Clinical Research Associate

Stephen Schlachter

Senior Scientist - Chemistry

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Edgewise Therapeutics

Answer: Edgewise Therapeutics's headquarters are located at 1715 38th St, Boulder, Colorado, 80301, United States

Answer: Edgewise Therapeutics's phone number is 72********

Answer: Edgewise Therapeutics's official website is https://edgewisetx.com

Answer: Edgewise Therapeutics's revenue is $25 Million to $50 Million

Answer: Edgewise Therapeutics's SIC: 2834

Answer: Edgewise Therapeutics has 51-200 employees

Answer: Edgewise Therapeutics is in Biotechnology

Answer: Edgewise Therapeutics contact info: Phone number: 72******** Website: https://edgewisetx.com

Answer: Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access